As Pennsylvania state lawmakers weigh key measures to protect residents from Big Pharma’s skyrocketing drug prices, patients are calling for reform.
We shouldn't have to decide if we would rather eat or treat our ailments.
I am currently prescribed a slew of high-priced drugs like Lipitor, and each month my prescriptions total about $500 –– which is much more than I can manage.
If my drugs were more affordable, my health would greatly improve. Lower prices would mean better access to the medications that are prescribed to me.
Read David Mitchell’s testimony covering his battle against multiple myeloma and imploring Congress to help patients.
David Mitchell, Patients For Affordable Drugs Founder, to stand up for patients in Senate hearing on balancing innovation and competition.
We are encouraged by continued Congressional action to address an array of abusive tactics Big Pharma uses to block competition and keep drug prices high.
Today’s congressional briefing featured a bipartisan panel of experts who agreed that International Reference Pricing can lower drug prices in the U.S. while maintaining innovation.
In the first three months of 2019, PhRMA spent $10 million for 27 in-house lobbyists and 20 outside lobbyists. Swampy.
I wish things were different, but for now, this is the way I must live.
The medications that help me should not take up 57% of my income.
My insulin was simply unaffordable, and my stress over it became a formidable aspect of my life.
Welcome to the week in drug pricing news — no redactions.
I don’t think I would be alive right now if I weren’t able to afford my medication.
Patients are turning up at statehouses to tell lawmakers just how harmful high drug prices have become — their voices are seeding a movement.
If I weren’t able to afford the Restasis, my eyes would dry out and I would have bad vision. In the long term, I would ultimately go blind.
Patient testimony to call for urgent action in Augusta to lower drug prices.
Hearings, new legislation, and committee passage mark a productive week for drug pricing.